Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

NHS England invites people aged 56 to 59 to book COVID-19 vaccinations in coming week

Published 03/06/2021, 11:29 PM
Updated 03/06/2021, 11:30 PM
© Reuters. COVID-19 vaccination centre in Southend-on-Sea

By Kanishka Singh

(Reuters) - NHS England has invited people aged 56 to 59 to book COVID-19 vaccinations in the coming week, with letters to 850,000 people in that age bracket landing on doorsteps from Saturday and another 850,000 due to land Monday.

"The latest invites have been sent after more than eight in 10 people aged 65 to 69 took up the offer of a jab", the National Health Service said in an emailed statement on Sunday.

"NHS staff have vaccinated more than 18 million people across England, meaning more than one third of the adult population have already received the life-saving jab."

Britain's medical regulator on Thursday said it would fast-track vaccines for coronavirus variants, adding that makers of already-authorised shots would not need new lengthy clinical trials to prove their adapted vaccines work.

There is concern that some variants, such as those first found in South Africa and Brazil, may reduce the efficacy of the first generation of COVID-19 vaccines, and manufacturers are looking to adapt their shots.

The accelerated process is based on that used for seasonal flu vaccines each year, the Medicines & Healthcare products Regulatory Agency (MHRA) said, and would be based on robust evidence that the shots create an immune response, rather than full clinical trials.

AstraZeneca (NASDAQ:AZN) PLC, Pfizer Inc (NYSE:PFE) and Moderna (NASDAQ:MRNA) Inc - makers of the three vaccines the MHRA has approved for use so far - have all said they aim to modify their shots to cope with variants this year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Britain has so far offered shots made by AstraZeneca and Pfizer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.